China billionaire Li’s biotech moves closer to new drug dream
Bloomberg Hutchison China MediTech Ltd., the biotechnology company backed by billionaire Li Ka-shing, reported positive late-stage results for its drug to treat colorectal cancer, taking the company one step closer to having a home-grown therapy on the market. The Hong Kong-based company, known as Chi-Med, said in a statement that it is currently preparing to submit a new drug ...
Read More »